Programs

The Role of Targeted Therapies in the Treatment
of Metastatic Colorectal Cancer

This continuing education monograph activity was created to provide oncologists with current perspectives and expert commentary on the role of targeted agents in the treatment of metastatic colorectal cancer (mCRC). Topics discussed in this program are the latest study results on the use of targeted agents in the treatment of mCRC, effective regimens employing vascular endothelial growth factor inhibitors and epidermal growth factor receptor inhibitors in various lines of treatment, and clinical approaches for individualized treatment using chemotherapeutic and targeted agents. This activity is supported by an educational donation provided by Amgen. (For inquiries regarding this continuing education program, e-mail sleigh@cealliance.org

Release date: February 28 , 2007 Expiration: February 28, 2008

This activity has expired. The accredited provider can no longer issue certificates for this activity.


		Download Now